Immunology
Neuropeptide May Serve as Biomarker for Neuroblastoma Patients
A study has found the common nerve protein Neuropeptide Y (NPY) to be elevated in the blood of those with an aggressive form of neuroblastoma, suggesting that NPY could serve as biomarker in a prognostic and/or treatment monitoring test, and as a new target for developing a more effective therapeutic drug for this early childhood cancer. More...26 Oct 2016
Unnecessary Endoscopies Could Be Avoided with Fecal Blood Test
The majority of primary care patients referred for bowel endoscopy do not have significant colorectal disease (SCD), and are unnecessarily exposed to a small but realistic risk of severe endoscopy-associated complications. More...14 Oct 2016
Quick Test Detects Inflammation in Diabetic Patients
A new kit has been developed that will allow doctors to find out within minutes if diabetic patients are suffering from inflammation. Current procedures require patients to wait for several hours for the results obtained from the conventional full blood count test. More...12 Oct 2016
Anti-Treponema Immunohistochemistry Cross-Reactivity Reported with Non-Treponema Spirochetes
Syphilis has different histopathologic presentations, and it can mimic a significant number of entities while human intestinal spirochetosis is characterized by the presence of a layer of spirochetes adherent to the apical epithelial surface of the colorectal mucosa. More...12 Oct 2016
Increased Serum Cytokine Concentrations Reported in Guillain-Barré Syndrome
Guillain-Barré syndrome (GBS) is an acquired demyelinating peripheral neuropathy and it has been shown that macrophage activation contribute to the pathogenesis of GBS. Therefore macrophage-mediated factors could be the potential markers for disease diagnosis and status of GBS. More...05 Oct 2016
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Clinical Informatics Platform
CLARION™
HPV Test
Allplex HPV28 Detection
In Other News
Effectiveness of PD-L1 Tests Compared for Non-Small-Cell Lung Cancer
Screening for Latent Tuberculosis Infection Recommended
Method Developed Predicts Disease Activity in Multiple Sclerosis
Novel Turbidimetric Immunoassay Evaluated for Fecal Calprotectin
Optimal Rule-Out Biomarker Strategy Developed for Acute MI
Field Performance for Rapid Detection of Influenza Virus Analyzed
POC Diagnostic Tool Introduced for Allergic Disorder Biomarker
Sensitive Clinical Marker Defined for Ulcerative Colitis Evolution
Combined Use of Assays Identifies Cancer Patient Response to Crizotinib
Biomarker Outperforms Current Gold Standard to Detect Brain Shunt Infections
Circulating Immune Cells Act As Idiopathic Pulmonary Fibrosis Biomarkers
Guide Helps Physicians Diagnose and Manage Food Allergies
Lung Eosinophils Play Protective and Beneficial Role
Certification Enables Development of New Technology in Next-Gen Immunodiagnostics
Immune Analysis of Biopsies Predicts Response to Melanoma Immunotherapy
Innate Immune Sensor of Microbial Proteolysis Revealed
Latent Toxoplasmosis Prevalence Analyzed Retrospectively
Simplified Assay Quantifies Circulating Activated Protein C
Lateral Flow-Based Antibody Test Developed for Trachoma
Neutrophil CD64 Index Helps Diagnose Spontaneous Bacterial Peritonitis
Next-Generation Systems Introduced for Clinical Laboratories
High-Sensitivity Micro LC-MS/MS Assay Developed for Serum Estradiol
Immunoassay Evaluated for Quantitative Measurement of Fecal α1-Antitrypsin
The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.